Cutaneous Oncology News

Patients with cutaneous squamous cell carcinoma with perineural invasion who underwent adjuvant radiotherapy in addition to Mohs micrographic surgery experienced improved outcomes compared with patients who underwent surgery alone.

Nearly 90% of a small cohort of individuals with mycosis fungoides responded to intervention with a condensed, low dose of total skin electron beam therapy, according to a study.

Concern for patients along with malpractice fears influence dermatopathologists’ actions in ordering additional tests and services in melanocytic skin lesions, according to a study.

The FDA today approved atezolizumab plus cobimetinib and vemurafenib for the treatment of patients with BRAF V600-positive advanced melanoma, according to a manufacturer-issued press release.

Atopic eczema carried no association with overall cancer risk but was associated with non-Hodgkin and Hodgkin lymphoma, according to results of two large population-based studies.

Baseline characteristics such as albumin, creatinine and BMI are useful biomarkers to aid in the management of patients with melanoma who are undergoing pembrolizumab treatment.

Both surgery and radiation therapy were beneficial methods of treating early-stage lip squamous cell carcinoma, according to findings presented at the American Academy of Dermatology virtual meeting.

Janice M. Mehnert, MD, has been appointed associate director for clinical research at NYU Langone Health’s Perlmutter Cancer Center.

The FDA approved pembrolizumab for treatment of recurrent or metastatic cutaneous squamous cell carcinoma that is not curable by surgery or radiation.

Treatment with sonidegib was safe and effective in patients with locally advanced basal cell carcinoma, according to study results presented at the American Academy of Dermatology virtual meeting.